Allergan Aesthetics, an AbbVie Company · 1 month ago
2026 Preclinical Study Design & Assay Development Intern
AbbVie is a leader in the pharmaceutical industry focused on discovering and delivering innovative medicines. They are seeking a motivated intern to support the Regenerative Medicine group by assisting in the design and execution of preclinical studies and developing in vitro assays related to tissue engineering and biomaterials research.
BeautyManufacturingPharmaceuticalWellness
Responsibilities
Support pre-clinical study planning, data collection, and documentation
Assist in developing and validating in vitro testing assays
Collaborate with scientists to optimize experimental protocols
Perform literature reviews and help analyze experimental data
Present findings in team meetings and prepare technical reports
Qualification
Required
Currently enrolled in university, pursuing a Bachelor's in: Biomedical Engineering, Biology, or related field
Basic understanding of tissue engineering or materials science
Strong organizational and communication skills
Must be enrolled in university for at least one semester following the internship
Expected graduation date between December 2026 – June 2027
Preferred
Laboratory experience with cell culture, microscopy, or biochemical assays preferred
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
Allergan Aesthetics, an AbbVie Company
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products.
H1B Sponsorship
Allergan Aesthetics, an AbbVie Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2023 (1)
2022 (16)
2021 (14)
2020 (5)
Funding
Current Stage
Late StageLeadership Team
Recent News
2025-12-04
Company data provided by crunchbase